Abstract

Plasma glycoproteins and extracellular vesicles represent excellent sources of disease biomarkers, but laboratory detection of these circulating structures are limited by their relatively low abundance in complex biological fluids. Although intensive research has led to the development of effective methods for the enrichment and isolation of either plasma glycoproteins or extracellular vesicles from clinical materials, at present it is not possible to enrich both structures simultaneously from individual patient sample, a method that affords the identification of biomarker combinations from both entities for the prediction of clinical outcomes will be clinically useful. We have therefore developed an enrichment method for use in mass spectrometry-based proteomic profiling that couples prolonged ultracentrifugation with electrostatic repulsion-hydrophilic interaction chromatography, to facilitate the recovery of both glycoproteins and extracellular vesicles from nondepleted human plasma. Following prolonged ultracentrifugation, plasma glycoproteins and extracellular vesicles were concentrated as a yellow suspension, and simultaneous analyses of low abundant secretory and vesicular glycoproteins was achieved in a single LC-MS/MS run. Using this systematic prolonged ultracentrifugation-electrostatic repulsion-hydrophilic interaction chromatography approach, we identified a total of 127 plasma glycoproteins at a high level of confidence (FDR ≤ 1%), including 48 glycoproteins with concentrations ranging from pg to ng/ml. The novel enrichment method we report should facilitate future human plasma-based proteome and glycoproteome that will identify novel biomarkers, or combinations of secreted and vesicle-derived biomarkers, that can be used to predict clinical outcomes in human patients.

Highlights

  • Ultracentrifugation-electrostatic repulsion-hydrophilic interaction chromatography approach, we identified a total of 127 plasma glycoproteins at a high level of confidence (FDR < 1%), including 48 glycoproteins with concentrations ranging from pg to ng/ml

  • We showed that glycoprotein enrichment by prolonged ultracentrifugation (PUC)-ERLIC facilitates the simultaneous recovery of both secretory and extracellular vesicle-derived glycoproteins from nondepleted human plasma, which could in part be attributed to the synergistic effects of using PUC and ERLIC in combination

  • When using PUC, we were able to recover a yellow, extracellular vesicle-containing fraction, and this fraction was found to be highly enriched in secretory glycoproteins that could potentially be probed for prognostic/diagnostic biomarkers

Read more

Summary

EXPERIMENTAL PROCEDURES

All water used in the experiments was prepared using a Milli-Q system (Millipore, Bedford, MA). Two biological replicates were performed in this study, and plasma samples from all 20 patients were combined in equal proportions to obtain a total volume of 5 ml prior to analysis (in order to minimize biological variation). In-Solution Tryptic Digestion—Proteomic sample preparation was performed according to previously described methods designed to minimize experimentally-induced deamidation [42, 43], except for minor modifications. Peptides were deglycosylated overnight at 37 °C and dried using a vacuum concentrator prior to reconstitution in LC-MS/MS compatible buffer (3% ACN, 0.1% FA). LC-MS/MS—The fractionated peptides were separated and analyzed using a LC-MS/MS system that comprised a Ultimate 3000 RSLC nano-HPLC system (Dionex, Amsterdam, NL) coupled to an online LTQ-FT Ultra linear ion trap mass spectrometer (Thermo Scientific Inc., Bremen, Germany). Peptide sequences were submitted to NCBI BLASTP [50, 51] search against a nonredundant protein sequences (nr) using NCBI server default settings

RESULTS AND DISCUSSION
58 P04275
CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call